Stay updated with breaking news from Michael Rosol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(2022-05-24 | NYSEAM:NAVB) Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting
Navidea Biopharmaceuticals Announces the Regulatory Approval of Lymphoaim in India - read this article along with other careers information, tips and advice on BioSpace
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace
Navidea Biopharmaceuticals Announces Research Agreement with the University of Pennsylvania Evaluating Tc99m Tilmanocept as a Prognostic Marker for Glioblastoma - read this article along with other careers information, tips and advice on BioSpace
13.12.2021 - Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the results of a third-party asset valuation of ... Seite 1